Nissan Chemical Corporation

DB:NSC Stock Report

Market Cap: €4.5b

Nissan Chemical Valuation

Is NSC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NSC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NSC (€32.8) is trading below our estimate of fair value (€35.51)

Significantly Below Fair Value: NSC is trading below fair value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for NSC?

Key metric: As NSC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for NSC. This is calculated by dividing NSC's market cap by their current earnings.
What is NSC's PE Ratio?
PE Ratio19x
EarningsJP¥39.06b
Market CapJP¥742.81b

Price to Earnings Ratio vs Peers

How does NSC's PE Ratio compare to its peers?

The above table shows the PE ratio for NSC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.1x
BAS BASF
76.9x34.2%€38.2b
FPE3 Fuchs
19x8.9%€5.0b
WCH Wacker Chemie
29.1x37.0%€3.6b
EVK Evonik Industries
35.6x33.1%€8.2b
NSC Nissan Chemical
19x6.1%€742.8b

Price-To-Earnings vs Peers: NSC is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (40.1x).


Price to Earnings Ratio vs Industry

How does NSC's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
NSC 19.0xIndustry Avg. 17.0xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: NSC is expensive based on its Price-To-Earnings Ratio (19x) compared to the European Chemicals industry average (17.1x).


Price to Earnings Ratio vs Fair Ratio

What is NSC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NSC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio19x
Fair PE Ratio14.3x

Price-To-Earnings vs Fair Ratio: NSC is expensive based on its Price-To-Earnings Ratio (19x) compared to the estimated Fair Price-To-Earnings Ratio (14.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NSC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€32.80
€38.44
+17.2%
9.7%€42.76€31.77n/a9
Nov ’25€30.80
€38.31
+24.4%
10.1%€42.36€31.47n/a9
Oct ’25€31.60
€39.24
+24.2%
11.1%€43.97€32.66n/a9
Sep ’25€31.00
€38.56
+24.4%
11.1%€43.28€32.15n/a9
Aug ’25€28.80
€37.82
+31.3%
9.8%€42.00€31.20n/a9
Jul ’25€28.40
€36.34
+28.0%
10.5%€41.20€30.18n/a8
Jun ’25€26.20
€39.77
+51.8%
9.0%€45.72€33.41n/a9
May ’25€32.20
€41.07
+27.5%
9.3%€47.29€33.95n/a9
Apr ’25€34.80
€41.13
+18.2%
9.2%€47.92€34.40n/a9
Mar ’25€38.20
€40.11
+5.0%
7.5%€46.40€34.46n/a9
Feb ’25€36.60
€39.56
+8.1%
9.4%€46.76€32.87n/a9
Jan ’25€35.00
€40.90
+16.9%
9.3%€48.18€33.87n/a9
Dec ’24€32.80
€41.09
+25.3%
12.6%€50.12€32.79n/a10
Nov ’24€38.40
€44.37
+15.6%
10.8%€51.35€36.77€30.8010
Oct ’24€40.20
€44.13
+9.8%
11.1%€51.21€36.67€31.6010
Sep ’24€39.20
€43.58
+11.2%
11.2%€51.11€36.60€31.009
Aug ’24€40.80
€44.13
+8.2%
11.3%€52.08€37.29€28.809
Jul ’24€38.60
€43.89
+13.7%
11.0%€52.75€37.77€28.4010
Jun ’24€40.20
€44.89
+11.7%
11.5%€54.27€38.86€26.2010
May ’24€40.00
€45.81
+14.5%
12.3%€56.03€39.63€32.2010
Apr ’24€40.80
€47.31
+16.0%
14.6%€61.80€40.27€34.8010
Mar ’24€40.80
€48.65
+19.2%
14.1%€61.29€39.94€38.2010
Feb ’24€42.00
€50.85
+21.1%
13.7%€62.42€40.68€36.6010
Jan ’24€40.00
€51.35
+28.4%
13.2%€63.32€42.76€35.009
Dec ’23€46.80
€52.38
+11.9%
12.5%€62.11€43.61€32.809
Nov ’23€44.20
€52.84
+19.6%
11.9%€62.19€44.17€38.409

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies